SCHEMBL19980873

SCHEMBL19980873

CC1OC(OC2C(C(=O)O)OC(OC3C(OC4C(OCC(F)(F)CN)OC(C)C(O)C4O)OC(C)C(O)C3O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IGF2R P11717 2/20 0.46
AMY1A P0DUB6 1/20 0.41
CD209 Q9NNX6 2/20 0.41
SELE P16581 3/20 0.40
SELL P14151 2/20 0.37
SELP P16109 2/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
XDH P47989 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM1A O60341 1/20 0.36
PRKCA P17252 1/20 0.36
BACE1 P56817 1/20 0.36
STAT3 P40763 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18122118 0.87 IGF2R (0.43) IGF2RCD209ALDH1A1HSD17B10
SCHEMBL19980831 0.84 IGF2R (0.54) IGF2RAMY1ACD209SELESELL
SCHEMBL24107790 0.83 IGF2R (0.52) IGF2RCD209ALDH1A1ALOX15
SCHEMBL19980886 0.83 IGF2R (0.53) IGF2RAMY1ACD209SELESELL
SCHEMBL19980877 0.83 IGF2R (0.53) IGF2RAMY1ACD209SELESELL
SCHEMBL19980809 0.82 IGF2R (0.56) IGF2RAMY1ACD209SELESELL
SCHEMBL19980817 0.82 IGF2R (0.54) IGF2RAMY1ACD209SELESELL
SCHEMBL24107897 0.80 CD209 (0.53) IGF2RCD209ALDH1A1
SCHEMBL19980833 0.80 SELE (0.48) IGF2RAMY1ASELESELLSELP
SCHEMBL24250552 0.78 SELE (0.45) IGF2RAMY1ACD209SELESELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10688169-B2 Vaccines against carbapenem-resistant Klebsiella pneumoniae MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2020-06-23 US disclosed
US-20180078630-A1 VACCINES AGAINST CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10688169-B2 Vaccines against carbapenem-resistant Klebsiella pneumoniae UBXN1, FUT5, SLC11A2 IGF2R 576/4885AMY1A 3497/4885CD209 344/4885
US-20180078630-A1 VACCINES AGAINST CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE UBXN1, FUT5, SLC11A2 IGF2R 576/4885AMY1A 3497/4885CD209 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.